Silo Pharma's subsidiary, QwikAgents, has joined the AMD AI Developer Program to enhance its AI agent platform.
This collaboration grants QwikAgents access to AMD Developer Cloud credits and a suite of AI development tools aimed at accelerating the innovation of enterprise AI agents. Eric Weisblum, CEO of Silo Pharma, emphasized that these resources will facilitate the development, testing, and deployment of AI agents tailored for various applications, from content generation to workflow automation. The initiative seeks to democratize access to advanced AI technology, making it available to both enterprises and individual users.
The QwikAgents platform is designed to provide persistent AI agents that can be customized for diverse tasks, including scheduling and coding. With subscription plans starting at $14 per month, the platform aims to cater to a broad audience, including small businesses and developers. Key features include persistent memory, smart model routing, and a straightforward deployment process, all of which are intended to enhance user experience and operational efficiency.
By leveraging AMD's resources, QwikAgents plans to improve the reliability and scalability of its AI agents, enabling them to perform complex tasks with minimal human intervention. This strategic partnership not only positions QwikAgents for growth but also highlights the increasing importance of AI in streamlining business operations across various sectors.